These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32238418)

  • 1. Oxygen Surrogate Systems for Supporting Human Drug-Metabolizing Cytochrome P450 Enzymes.
    Strohmaier SJ; De Voss JJ; Jurva U; Andersson S; Gillam EMJ
    Drug Metab Dispos; 2020 Jun; 48(6):432-437. PubMed ID: 32238418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel laser dye substrate of mammalian cytochromes P450: application in rapid kinetic analysis, inhibitor screening, and directed evolution.
    Kumar S
    J Biomol Screen; 2007 Aug; 12(5):677-82. PubMed ID: 17478480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human recombinant cytochrome P450 enzymes display distinct hydrogen peroxide generating activities during substrate independent NADPH oxidase reactions.
    Mishin V; Heck DE; Laskin DL; Laskin JD
    Toxicol Sci; 2014 Oct; 141(2):344-52. PubMed ID: 25061110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P450BM-3; a tale of two domains--or is it three?
    Peterson JA; Sevrioukova I; Truan G; Graham-Lorence SE
    Steroids; 1997 Jan; 62(1):117-23. PubMed ID: 9029725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indole hydroxylation by bacterial cytochrome P450 BM-3 and modulation of activity by cumene hydroperoxide.
    Li QS; Ogawa J; Schmid RD; Shimizu S
    Biosci Biotechnol Biochem; 2005 Feb; 69(2):293-300. PubMed ID: 15725653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directed evolution of cytochrome P450 enzymes for biocatalysis: exploiting the catalytic versatility of enzymes with relaxed substrate specificity.
    Behrendorff JB; Huang W; Gillam EM
    Biochem J; 2015 Apr; 467(1):1-15. PubMed ID: 25793416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in human drug metabolizing cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 activities caused by genetic variations in cytochrome P450 oxidoreductase.
    Velazquez MNR; Parween S; Udhane SS; Pandey AV
    Biochem Biophys Res Commun; 2019 Jul; 515(1):133-138. PubMed ID: 31128914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Higher-Throughput Cytochrome P450 Inhibition Assay with the Novel Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Human Hepatocytes).
    Palacharla VRC; Chunduru P; Ajjala DR; Bhyrapuneni G; Nirogi R; Li AP
    Drug Metab Dispos; 2019 Oct; 47(10):1032-1039. PubMed ID: 31375472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity in mechanisms of substrate oxidation by cytochrome P450 2D6. Lack of an allosteric role of NADPH-cytochrome P450 reductase in catalytic regioselectivity.
    Hanna IH; Krauser JA; Cai H; Kim MS; Guengerich FP
    J Biol Chem; 2001 Oct; 276(43):39553-61. PubMed ID: 11509577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic Deuterium Isotope Effects in Cytochrome P450 Reactions.
    Guengerich FP
    Methods Enzymol; 2017; 596():217-238. PubMed ID: 28911772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diclofenac and its derivatives as tools for studying human cytochromes P450 active sites: particular efficiency and regioselectivity of P450 2Cs.
    Mancy A; Antignac M; Minoletti C; Dijols S; Mouries V; Duong NT; Battioni P; Dansette PM; Mansuy D
    Biochemistry; 1999 Oct; 38(43):14264-70. PubMed ID: 10572000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of intersystem extrapolation factors in early reaction phenotyping and the quantitative extrapolation of human liver microsomal intrinsic clearance using recombinant cytochromes P450.
    Chen Y; Liu L; Nguyen K; Fretland AJ
    Drug Metab Dispos; 2011 Mar; 39(3):373-82. PubMed ID: 21148079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite.
    Kazui M; Nishiya Y; Ishizuka T; Hagihara K; Farid NA; Okazaki O; Ikeda T; Kurihara A
    Drug Metab Dispos; 2010 Jan; 38(1):92-9. PubMed ID: 19812348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of copper (II) on the cytochrome P450 enzymes and NADPH-cytochrome P450 reductase: inhibition of cytochrome P450-catalyzed reactions by copper (II) ion.
    Kim JS; Ahn T; Yim SK; Yun CH
    Biochemistry; 2002 Jul; 41(30):9438-47. PubMed ID: 12135366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of chemical auxiliaries to control p450 enzymes for predictable oxidations at unactivated C-h bonds of substrates.
    Auclair K; Polic V
    Adv Exp Med Biol; 2015; 851():209-28. PubMed ID: 26002737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4, to the hepatic metabolism of the proteasome inhibitor bortezomib.
    Uttamsingh V; Lu C; Miwa G; Gan LS
    Drug Metab Dispos; 2005 Nov; 33(11):1723-8. PubMed ID: 16103134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous detection of NADPH consumption and H
    Morlock LK; Böttcher D; Bornscheuer UT
    Appl Microbiol Biotechnol; 2018 Jan; 102(2):985-994. PubMed ID: 29150709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes.
    Shimada T; Mernaugh RL; Guengerich FP
    Arch Biochem Biophys; 2005 Mar; 435(1):207-16. PubMed ID: 15680923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into Praziquantel Metabolism and Potential Enantiomeric Cytochrome P450-Mediated Drug-Drug Interaction.
    Vendrell-Navarro G; Scheible H; Lignet F; Burt H; Luepfert C; Marx A; Abla N; Swart P; Perrin D
    Drug Metab Dispos; 2020 Jun; 48(6):481-490. PubMed ID: 32193358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems.
    Guengerich FP; Johnson WW
    Biochemistry; 1997 Dec; 36(48):14741-50. PubMed ID: 9398194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.